On Tuesday, E-House (China) Holdings Limited (ADR) (NYSE:EJ)’s shares declined -2.78% to $6.30, as E-House, declared that it has reached a definitive contract with Jupai Holdings Limited Jupai, a leading third-party wealth administration service provider in China, regarding the projected transfer of E-House Capital, the asset administration business unit of E-House focusing on the design and administration of real estate or related investment projects and funds, to Jupai. E-House, through E-House Capital Investment Administration Limited, a wholly owned partner of E-House, presently owns about 33% of the total issued and outstanding shares of Jupai.
E-House (China) Holdings Limited, through its auxiliaries, operates as a real estate services corporation primarily in the People’s Republic of China. It operates through Real Estate Online Services, Real Estate Brokerage Services, Real Estate Information and Consulting Services, and Other Services segments.
21Vianet Group Inc (NASDAQ:VNET)’s shares dropped -2.70% to $19.98, during the last trading session on Tuesday, as 21Vianet Group, declared that it has filed its annual report containing its audited merged financial statements on Form 20-F for the fiscal year ended December 31, 2014 with the Securities and Exchange Commission on April 10, 2015. The annual report can be accessed on 21Vianet’s investor relations website at http://ir.21vianet.com/. The Corporation will provide hardcopies of the annual report, free of charge, to its shareholders and ADS holders upon request.
21Vianet Group, Inc. provides carrier-neutral Internet data center services to Internet companies, government entities, blue-chip enterprises, and small- to mid-sized enterprises in the People’s Republic of China. It offers hosting and related services to house servers and networking equipment in its data centers, and connects them through a data transmission network; and other hosting related value-added services.
At the end of Tuesday’s trade, Atmel Corporation (NASDAQ:ATML)‘s shares dipped -2.72% to $8.22, as Atmel®, declared the corporation is the first to receive the PRIME (PoweRline Intelligent Metering Evolution) v1.4 Profile 2 certification for the Atmel | SMART SAM4CP16B and ATPL230A smart metering solutions. The certification extends Atmel’s leadership and commitment to delivering state-of-the-art connectivity solutions and ensures that the corporation’s customers are able to develop high performance solutions, incorporating new features of the PRIME v1.4 standard. The latest PRIME standard supports some of the most demanding requirements of smart metering systems by offering raised robustness, throughput, band expansion, band-plan flexibility and IP version 6.
Atmel Corporation designs, develops, manufactures, and sells semiconductor integrated circuit products primarily in the United States, Asia, Europe, South Africa, and Central and South America. It operates in four segments: Microcontroller, Nonvolatile Memory, Automotive, and Multi-Market and Other.
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), ended its Tuesday’s trading session with -2.66% loss, and closed at $64.81, as Isis Pharmaceuticals, declared that administration will present a corporation overview at the following investor conferences:
40th Annual Deutsche Bank Health Care Conference on Thursday, May 7, 2015 in Boston, MA;
2015 Bank of America Merrill Lynch Health Care Conference on Tuesday, May 12, 2015 in Las Vegas; and
2015 UBS Global Healthcare Conference on Tuesday, May 19, 2015 in New York, NY.
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The corporation’s flagship product comprises the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
